Device Cos. Face Slim Chance Of Tax Repeal After ACA Ruling

Law360, New York (June 29, 2012, 7:29 PM EDT) -- Manufacturers of artificial joints, synthetic heart valves and other sophisticated medical devices say they'll continue fighting an industry tax contained in the U.S. Supreme Court-approved health care reform law, but their odds of success look increasingly slim, experts said Friday.

At issue is a 2.3 percent excise tax that would take effect Jan. 1 and raise $29 billion over the next decade — money seen as vital to funding expanded coverage in the Patient Protection and Affordable Care Act. After the high court gave its blessing...
To view the full article, register now.